Shen Yanjie, Shi Geyong, Wen Shumei, Luo Wei, Wang Ke
Guilin Maternal and Child Health Hospital, Guilin, Guangxi, China.
BMC Pediatr. 2025 May 1;25(1):348. doi: 10.1186/s12887-025-05699-1.
Short stature in children is a common concern that can result from various underlying conditions. While factors such as growth hormone deficiency and nutritional deficiencies are well-known contributors, the role of vitamin K2 (VK2) in the development of short stature remains underexplored. This study aimed to investigate the association between VK2 status and short stature in children.
A total of 730 children aged 3-16 years were enrolled and divided into three groups: short stature group (n = 191), near-short stature group (n = 357), and normal stature group (n = 182). Clinical characteristics and growth-related indicators including serum VK2 levels, bone mineral density (BMD), insulin-like growth factor 1 (IGF-1), and 25-hydroxyvitamin D (25-(OH)D) were collected. VK2 was analyzed both as a categorical variable (VK2 deficiency vs. normal status) and as a continuous variable, logistic regression models were applied to assess the association between VK2 status and short stature using both approaches. Correlations between VK2 status and other growth-related indicators were also examined.
The prevalence of VK2 deficiency was higher in children with short stature (80.6%) and near-short stature (64.7%) compared to those with normal stature (32.4%) (P < 0.05). Multiple logistic regression models showed that higher serum VK2 levels were significantly associated with a decreased risk of short stature (aOR = 0.005, 95% CI: 0.001-0.036) and near-short stature (aOR = 0.023, 95% CI: 0.006-0.085); and VK2 deficiency was significantly associated with increased risk of short stature (aOR = 5.934, 95% CI: 3.372-10.443) and near-short stature (aOR = 3.233, 95% CI: 2.095-4.989) after adjusting for covariates. Additionally, serum VK2 levels were positively correlated with IGF-1-SDS and 25(OH)D (P < 0.05).
VK2 deficiency was significantly associated with an increased risk of short stature in children. Further longitudinal studies are warranted to elucidate the causal relationship between VK2 deficiency and growth disorders in pediatric populations.
儿童身材矮小是一个常见问题,可能由多种潜在疾病引起。虽然生长激素缺乏和营养缺乏等因素是众所周知的影响因素,但维生素K2(VK2)在身材矮小发展中的作用仍未得到充分研究。本研究旨在调查儿童VK2状态与身材矮小之间的关联。
共纳入730名3至16岁的儿童,分为三组:身材矮小组(n = 191)、接近身材矮小组(n = 357)和正常身材组(n = 182)。收集临床特征和与生长相关的指标,包括血清VK2水平、骨密度(BMD)、胰岛素样生长因子1(IGF-1)和25-羟基维生素D(25-(OH)D)。VK2既作为分类变量(VK2缺乏与正常状态)进行分析,也作为连续变量进行分析,应用逻辑回归模型使用这两种方法评估VK2状态与身材矮小之间的关联。还检查了VK2状态与其他生长相关指标之间的相关性。
与正常身材儿童(32.4%)相比,身材矮小儿童(80.6%)和接近身材矮小儿童(64.7%)的VK2缺乏患病率更高(P < 0.05)。多因素逻辑回归模型显示,较高的血清VK2水平与身材矮小风险降低(调整比值比[aOR]=0.005,95%置信区间[CI]:0.001 - 0.036)和接近身材矮小风险降低(aOR = 0.023,95% CI:0.006 - 0.085)显著相关;在调整协变量后,VK2缺乏与身材矮小风险增加(aOR = 5.934,95% CI:3.372 - 10.443)和接近身材矮小风险增加(aOR = 3.233,95% CI:2.095 - 4.989)显著相关。此外,血清VK2水平与IGF-1标准差评分和25(OH)D呈正相关(P < 0.05)。
VK2缺乏与儿童身材矮小风险增加显著相关。有必要进行进一步的纵向研究,以阐明儿童人群中VK2缺乏与生长障碍之间的因果关系。